Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kurt Brorson

Showing results (11-20 of 67) with videos related to

Pageof 7
Sort By:
Current Opinion in Biotechnology|July 16, 2014
Therapeutic monoclonal antibodies and consistent ends: terminal heterogeneity, detection, and impact on qualityKurt Brorson, Audrey Y Jia
Biotechnology and Bioengineering|December 19, 2008
Disposable bioprocessing: the future has arrivedGovind Rao, Antonio Moreira, Kurt Brorson
PDA Journal of Pharmaceutical Science and Technology|February 19, 2015
Proceedings of the 2013 Viral Clearance Symposium (Princeton, NJ)David Roush, Kurt Brorson, Rich Levy
Biotechnology and Bioengineering|January 15, 2010
Analysis of viral clearance unit operations for monoclonal antibodiesGeorge Miesegaes, Scott Lute, Kurt Brorson
PDA Journal of Pharmaceutical Science and Technology|February 14, 2006
Nomenclature standardization for 'large pore size' virus-retentive filtersKurt Brorson, Gail Sofer, Hazel Aranha
Nature Biotechnology|June 9, 2012
The need for innovation in biomanufacturingUwe Gottschalk, Kurt Brorson, Abhinav A Shukla
Journal of Chromatography. A|March 19, 2003
Identification of protein A media performance attributes that can be monitored as surrogates for retrovirus clearance during extended re-useKurt Brorson, Janice Brown, Elizabeth Hamilton, et al.
Biotechnology Progress|August 14, 2012
Chemometrics applications in biotechnology processes: predicting column integrity and impurity clearance during reuse of chromatography resinAnurag S Rathore, Shachi Mittal, Scott Lute, et al.
Biotechnology and Applied Biochemistry|February 9, 2007
Phage passage after extended processing in small-virus-retentive filtersScott Lute, Mark Bailey, Jessica Combs, et al.
Trends in Biotechnology|March 27, 2016
N-Glycosylation Design and Control of Therapeutic Monoclonal AntibodiesSha Sha, Cyrus Agarabi, Kurt Brorson, et al.
Pageof 7

Showing results (11-20 of 67) with videos related to

Sort By:
Pageof 7
Current Opinion in Biotechnology|July 16, 2014
Therapeutic monoclonal antibodies and consistent ends: terminal heterogeneity, detection, and impact on qualityKurt Brorson, Audrey Y Jia
Biotechnology and Bioengineering|December 19, 2008
Disposable bioprocessing: the future has arrivedGovind Rao, Antonio Moreira, Kurt Brorson
PDA Journal of Pharmaceutical Science and Technology|February 19, 2015
Proceedings of the 2013 Viral Clearance Symposium (Princeton, NJ)David Roush, Kurt Brorson, Rich Levy
Biotechnology and Bioengineering|January 15, 2010
Analysis of viral clearance unit operations for monoclonal antibodiesGeorge Miesegaes, Scott Lute, Kurt Brorson
PDA Journal of Pharmaceutical Science and Technology|February 14, 2006
Nomenclature standardization for 'large pore size' virus-retentive filtersKurt Brorson, Gail Sofer, Hazel Aranha
Nature Biotechnology|June 9, 2012
The need for innovation in biomanufacturingUwe Gottschalk, Kurt Brorson, Abhinav A Shukla
Journal of Chromatography. A|March 19, 2003
Identification of protein A media performance attributes that can be monitored as surrogates for retrovirus clearance during extended re-useKurt Brorson, Janice Brown, Elizabeth Hamilton, et al.
Biotechnology Progress|August 14, 2012
Chemometrics applications in biotechnology processes: predicting column integrity and impurity clearance during reuse of chromatography resinAnurag S Rathore, Shachi Mittal, Scott Lute, et al.
Biotechnology and Applied Biochemistry|February 9, 2007
Phage passage after extended processing in small-virus-retentive filtersScott Lute, Mark Bailey, Jessica Combs, et al.
Trends in Biotechnology|March 27, 2016
N-Glycosylation Design and Control of Therapeutic Monoclonal AntibodiesSha Sha, Cyrus Agarabi, Kurt Brorson, et al.
Pageof 7